Actively Recruiting
Comparing Oral Beta-Lactam and Non-Beta-Lactam Antibiotics for Treating Bone Infections in the Leg and Foot
Led by Michael Garron Hospital · Updated on 2026-03-27
1418
Participants Needed
3
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating and comparing two types of oral antibiotics, beta-lactam and non-beta-lactam, for treating bone infections in the leg and foot, specifically lower extremity osteomyelitis. This Phase 4 clinical trial aims to determine if oral beta-lactam antibiotics work as well as oral non-beta-lactam antibiotics for this condition. Initially, the study will assess whether it is feasible to recruit participants and follow them successfully before expanding to fully answer the treatment comparison question. Participants will be randomly assigned to one of two groups one receiving an oral beta-lactam antibiotic such as penicillins or cephalosporins, and the other receiving an oral non-beta-lactam antibiotic like fluoroquinolones, lincosamides, or sulfonamides. Treatment duration is expected to be at least 28 additional days of antibiotic therapy from enrollment. The trial does not involve blinding, and the study starts on February 26, 2026, with a planned completion date in 2033. During the study, participants will be monitored for up to 24 weeks to evaluate the primary effectiveness outcomes related to their bone infection treatment. Secondary effectiveness outcomes will also be assessed up to 52 weeks. Researchers will track participants response to the antibiotics, adherence to treatment, and any safety concerns. The goal is to gather thorough data on how well each antibiotic class works for infections of the leg and foot bones.
CONDITIONS
Brief Title
Comparison of Oral Antibiotics For Bone Infections of the Leg and Foot
Research Team
C
Christopher Kandel, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here